PET imaging with 11C-acetate in prostate cancer: A biochemical, radiochemical and clinical perspective

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 5, 2008, Pages 942-949

  Soloviev, Dmitri ^a   Fini, Alberto ^b   Chierichetti, Franca ^b   Al Nahhas, Adil ^c   Rubello, Domenico ^d  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b San Giacomo Hospital   (Italy)

^c HAMMERSMITH HOSPITAL   (United Kingdom)

^d VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

11C acetate; Biochemical perspective; Clinical perspective; PET imaging; Prostate cancer; Radiochemical perspective

Indexed keywords

ACETIC ACID C 11; FLUORODEOXYGLUCOSE F 18; MONOCARBOXYLATE TRANSPORTER; ACETIC ACID DERIVATIVE; CARBON; CARBON 11 ACETATE; CARBON-11 ACETATE; DIAGNOSTIC AGENT; RADIOPHARMACEUTICAL AGENT;

BIOCHEMISTRY; CANCER DIAGNOSIS; CANCER STAGING; CITRIC ACID CYCLE; DIAGNOSTIC ACCURACY; DIFFERENTIAL DIAGNOSIS; DRUG ACCUMULATION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG UPTAKE; FOLLOW UP; HUMAN; ISOTOPE LABELING; LIVER CELL CARCINOMA; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PROSTATE CANCER; QUALITY CONTROL; RADIOCHEMISTRY; REVIEW; ARTICLE; MALE; METHODOLOGY; PROSTATE TUMOR; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

ACETATES; CARBON; DIAGNOSIS, DIFFERENTIAL; HUMANS; MALE; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PROSTATIC NEOPLASMS; RADIOPHARMACEUTICALS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 42149167252     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0662-4     Document Type: Review

References (33)

1. Chierichetti F, Lessi G, Bissoli S, Fini A, Marcolin M, Saitta B, et al. Preliminary experience with 11C-Acetate and PET7CT in prostate cancer. J Nucl Med 2005;(Supplement 2):46, May.
2. Albrecht S, Buchegger F, Soloviev D, Zaidi H, Vees H, Khan HG, et al. (11)C-Acetate PET in the early evaluation of prostate cancer recurrence. Eur J Nucl Med Mol Imaging 2007;34:185-96. DOI 10.1007/s00259-006-0163-x.
3. Pike VW, Eakins MN, Allan RM, Selwyn AP. Preparation of [11C] acetate-an agent for the study of myocardial metabolism by PET. Int J Appl Radiat Isot 1982;33:505-12.
4. Buxton DB, Schwaiger M, Nguyen A, Phelps ME, Schelbert HR. Radiolabeled acetate as a tracer of myocardial tricarboxylic acid cycle flux. Circ Res 1988;63:628-34.
5. Klein LJ, Visser FC, Knaapen P, Peters JH, Teule GJJ, Visser CA, et al. Carbon-11 acetate as a tracer of myocardial oxygen consumption. Eur J Nucl Med 2001;28:651-68. DOI 10.1007/s002590000472.
6. Ho C-L, Chen S, Yeung DWC, Cheng TKC. Dual-tracer PET/CT imaging in evaluation of metastatic hepatocellular carcinoma. J Nucl Med 2007;48:902-9.
7. Powles T, Murray I, Brock C, Oliver T, Avril N. Molecular positron emission tomography and PET/CT imaging in urological malignancies. Eur Urol 2007;51:1511-21.
8. 14C]acetate. J Nucl Med 2001;42:1243-50.
9. Bissoli S, Nicolato A, Foroni R, Medea S, Fini A, Marcolin M, et al. Preliminary experience with 11C-acetate in the diagnosis of suspected meningioma. Eur J Nuclear Med Mol Imaging 2006;Suppl 2:33, September.
10. Waniewski RA, Martin DL. Preferential utilisation of acetate by astrocytes is attributable to transport. J Neurosci 1998;18:5225-33.
11. Devlin TM editor. Textbook of biochemistry: with clinical correlations. 4th edn. USA: Wiley-Liss; 2006.
12. 3)acetate for in vivo studies of myocardium using PET. Nucl Med Biol 1994;21:1067-72.
13. Bauer DE, Hatzivassiliou G, Zhao F, Andreadis C, Thompson CB. ATP citrate lyase is an important component of cell growth and transformation. Oncogene 2005;24:6314-22. DOI 10.1038/sj.onc.1208773.
14. Luong A, Hannah VC, Brown MS, Goldstein JL. Molecular characterization of human acetyl-CoA synthetase, an enzyme regulated by sterol regulatory element-binding proteins. Biol Chem 2000;275:26458-66.
15. Fujino T, Kondo J, Ishikawa M, Morikawa K, Yamamoto TT. Acetyl-CoA synthetase 2, a mitochondrial matrix enzyme involved in the oxidation of acetate. J Biol Chem 2001;276:11420-6.
16. Menendez JA, Colomer R, Lupu R. Why does tumor-associated fatty acid synthase (oncogenic antigen-519) ignore dietary fatty acids? Med Hypotheses 2005;64:342-9.
17. Yoshimoto M, Waki A, Yonekura Y, Sadato N, Murata T, Omata N, et al. Characterization of acetate metabolism in tumor cells in relation to cell proliferation: acetate metabolism in tumor cells. Nucl Med Biol 2001;28:117-22.
18. Shreve P, Chiao P-C, Humes HD, Schwaiger M, Gross MD. Carbon-11C-acetate PET imaging in renal disease. J Nucl Med 1995;36:1595-160.
19. Ookhtens M, Kannan R, Lyon I, Baker N. Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol Regul Integr Comp Physiol 1984;247:146-53.
20. Kuhajda FP. Fatty-acid synthase and human cancer: new perspectives on its role in tumor biology. Nutrition 2000;16:202-8.
21. 1H MRS-visible lipids accumulate during apoptosis of lymphoma cells in vitro and in vivo. Magn Reson Med 2005;54:43-50.
22. Yahagi N, Shimano H, Hasegawa K, et al. Co-ordinate activation of lipogenic enzymes in hepatocellular carcinoma. Eur J Cancer 2005;41:1316-22.
23. Swinnen JV, Brusselmans K, Verhoeven G. Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care 2006;9:358-65.
24. Chajès V, Cambot M, Moreau K, Lenoir GM, Joulin V. Acetyl-CoA carboxylase α is essential to breast cancer cell survival. Cancer Res 2006;66:5287-94.
25. Schlichtholz B, Turyn J, Goyke E, Biernacki M, Jaskiewicz K, Sledzinski Z, et al. Enhanced citrate synthase activity in human pancreatic cancer. Pancreas 2005;30:99-104.
26. Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer 2006;5:17. DOI 10.1186/1476-4598-5-17.
27. Brusselmans K, De Schrijver E, Verhoeven G, Swinnen JV. RNA interference-mediated silencing of the acetyl-CoA-carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res 2005;65:6719-25.
28. Frohnert BI, Bernlohr DA. Regulation of fatty acid transporters in mammalian cells. Prog Lipid Res 2000;39:83-107.
29. Heemers H, Maes B, Foufelle F, Heyns W, Verhoeven G, Swinnen JV. Androgens stimulate lipogenic gene expression in prostate cancer cells by activation of the sterol regulatory element-binding protein cleavage activating protein/sterol regulatory element-binding protein pathway. Mol Endocrinol 2001;15:1817-28.
30. Rossi S, Graner E, Febbo P, et al. Fatty acid synthase expression defines distinct molecular signatures in prostate cancer. Mol Cancer Res 2003;1:707-15.
31. Arunakaran J, Balasubramanian K, Srinivasan N, Aruldhas MM, Govindarajulu P. Interaction of androgens and prolactin on prostatic enzymes of the pyruvate-malate cycle involved in lipogenesis in castrated mature monkey, Macaca radiata. Cytobios 1992;70:33-40.
32. 11C-acetate PET imaging of prostate cancer. J Nucl Med 2002;43:181-6.
33. 11C-acetate whole-body PET. J Nucl Med 2004;45:1233-6.